Market Recap: Viking Therapeutics Inc (VKTX)’s Negative Momentum, Closing at 73.35

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Viking Therapeutics Inc (NASDAQ: VKTX) was $73.35 for the day, down -1.57% from the previous closing price of $74.52. In other words, the price has decreased by -$1.57 from its previous closing price. On the day, 3.36 million shares were traded. VKTX stock price reached its highest trading level at $74.0292 during the session, while it also had its lowest trading level at $71.37.

Ratios:

Our analysis of VKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 36.47 and its Current Ratio is at 36.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on September 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $80.

On June 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.

Raymond James Upgraded its Outperform to Strong Buy on May 16, 2024, whereas the target price for the stock was revised from $115 to $116.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 28 ’24 when ZANTE GREG sold 131,687 shares for $76.61 per share. The transaction valued at 10,089,164 led to the insider holds 149,366 shares of the business.

GREG ZANTE bought 131,687 shares of VKTX for $10,275,537 on Oct 28 ’24. On Oct 25 ’24, another insider, Rouan Sarah Kathryn, who serves as the Director of the company, sold 11,000 shares for $80.89 each. As a result, the insider received 889,790 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 8304246784 and an Enterprise Value of 7244653568.

Stock Price History:

Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $9.25. The 50-Day Moving Average of the stock is 14.58%, while the 200-Day Moving Average is calculated to be 24.21%.

Shares Statistics:

VKTX traded an average of 3.36M shares per day over the past three months and 4742360 shares per day over the past ten days. A total of 111.44M shares are outstanding, with a floating share count of 107.90M. Insiders hold about 3.18% of the company’s shares, while institutions hold 74.07% stake in the company. Shares short for VKTX as of 1728950400 were 14393785 with a Short Ratio of 4.29, compared to 1726185600 on 15906671. Therefore, it implies a Short% of Shares Outstanding of 14393785 and a Short% of Float of 17.349999999999998.

Most Popular